NFKB1 and breast carcinoma: Cui et al. reported that hepatitis B X-interacting protein is a novel regulator of CD55 in breast cancer cells, acting via ERK1/2/NF-κB (NFKB) signaling to contribute to the protection of cells from complement attack [31].